Detalles de la búsqueda
1.
Modeling Cost-Effectiveness of On-Demand Treatment for Hereditary Angioedema Attacks.
J Manag Care Spec Pharm
; 26(2): 203-210, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31841366
2.
A Predictive Model to Estimate Cost Savings of a Novel Diagnostic Blood Panel for Diagnosis of Diarrhea-predominant Irritable Bowel Syndrome.
Clin Ther
; 38(7): 1638-1652.e9, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27261204
3.
Longitudinal assessment of the dose consistency of botulinum toxin type A (BOTOX) for cervical dystonia.
Adv Ther
; 22(1): 49-55, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-15943222
4.
Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: a retrospective review of randomly selected medical records.
Clin Ther
; 24(3): 378-96, 2002 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-11952022
5.
Three-year cost-effectiveness model for non-animal stabilized hyaluronic acid and dextranomer copolymer compared with sacral nerve stimulation after conservative therapy for the management of fecal incontinence.
Clin Ther
; 36(6): 890-905.e3, 2014 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24815061
6.
Retrospective evaluation of the dose of Dysport and BOTOX in the management of cervical dystonia and blepharospasm: the REAL DOSE study.
Mov Disord
; 20(8): 937-44, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15810022
Resultados
1 -
6
de 6
1
Próxima >
>>